We appreciate the work of the Senate Committee on Health, Education, Labor, and Pensions (HELP) in reauthorizing the Food and Drug Administration’s (FDA) user fee programs for generic drugs (GDUFA). The improvements in GDUFA III will speed patient access to safe, effective and more affordable generic medicines, especially complex generics. These improvements are real and measurable and worthy of the Committee’s support and Congress’ swift ratification.
